Physician
SupportProstate Diseases |
|||||
|
Viadur is indicated in the palliative treatment of advanced prostate cancer and not for benign prostatic hyperplasia or prostatitis. Bayer is not responsible for, and does not endorse, any of the information found on these pages. When faced with a prostate cancer diagnosis, it is important to know that you, your family, and your caregiver are not alone. In fact, prostate cancer is one of the common types of cancer found in American men.1 According to American Cancer Society estimates, 198,100 new cases of prostate cancer will be diagnosed in the United States in 2001.2 In order to begin to understand this disease, we need to begin with some basic background information about the prostate.
The prostate is a relatively small, walnut-sized gland surrounding the urethra (see graphic at right) at the base of the urinary bladder in males.3 The main role of the gland is to add vital nutrients and fluid to the sperm.4 As the gland enlarges from normal growth or from cancer, it may cause narrowing of the urinary passage making it difficult to urinate.5 The three most common types of prostate disease are benign prostate hyperplasia (BPH), prostatitis, and prostate cancer.6 Viadur is indicated in the palliative treatment of advanced prostate cancer and not for benign prostatic hyperplasia or prostatitis. References available at: http://www.viadur.com |
|||||
|
Important Safety Considerations See Your Healthcare Provider This information does not take the place of your doctor’s advice or instructions but should help answer some of the questions you might have about prostate cancer therapies. |
|||||
| Distributed and Marketed by: | Manufactured by: | ||||
![]() Bayer HealthCare Pharmaceuticals 6 West Belt, Wayne, NJ 07470 USA |
![]() |
![]() |
|||
|
© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark
of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals.
DUROS® is a registered trademark of ALZA Corporation. |
|||||